C4 Therapeutics Inc (CCCC)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -32.913 | -32.156 | -25.592 | -18.501 | -27.341 | -32.824 |
| Return on Equity (%) | 60.456 | 44.407 | -78.583 | -25.028 | -37.763 | -49.498 |
| Return on Invested Capital (%) | -114.337 | -288.628 | -42.059 | -30.273 | -62.142 | -74.932 |
| Operating Margin (%) | -81.135 | -155.722 | -198.018 | -178.545 | -405.065 | -625.554 |
| Net Profit Margin (%) | -124.494 | -199.088 | -199.834 | -183.23 | -412.191 | -638.336 |
| Book Value Per Share | 23.335 | -0.678 | 6.512 | 8.002 | 5.907 | 4.994 |
| Earnings Per Share | -18.004 | -29.83 | -1.538 | -1.723 | -2.618 | -2.689 |
| Cash Per Share | 27.118 | 63.454 | 4.215 | 1.563 | 0.608 | 2.569 |
| Working Capital Per Share | 74.37 | 44.237 | 7.819 | 5.637 | 4.963 | 4.635 |
| Operating Profit Per Share | 14.462 | 14.983 | 0.77 | 0.94 | 0.635 | 0.421 |
| EBIT Per Share | -11.733 | -23.332 | -1.553 | -1.723 | -2.618 | -2.663 |
| EBITDA Per Share | -11.733 | -23.332 | -1.553 | -1.723 | -2.618 | -2.663 |
| Free Cash Flow Per Share | -16.946 | -30.002 | -1.561 | -1.727 | -2.54 | -2.692 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 1.34M | 1.43M | 43.12M | 48.69M | 48.97M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | N/A | 48.95M | 48.97M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | -909.125 | -1081.987 | N/A | -933.235 | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | -925.246 | -1100.763 | N/A | -933.235 | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 304.24M |
| Price to Earnings Ratio | -2.24 |
| Price to Sales Ratio | 14.29 |
| Price to Cash Ratio | 2.34 |
| Price to Book Ratio | 1.2 |
| Dividend Yield | - |
| Shares Outstanding | 70.59M |
| Average Volume (1 week) | 1.01M |
| Average Volume (1 Month) | 862.04k |
| 52 Week Change | 127.03% |
| 52 Week High | 11.88 |
| 52 Week Low | 1.06 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
